Notification, 2018

Text

Reproduced from the document India Code holds for this instrument. The Gazette prints Hindi and English side by side and this is the English; the Department's own PDF remains the authority.

EXTRAORDINARY

PUBLISHED BY AUTHORITY

No. 177] NEW DELHI, FRIDAY, MARCH 23, 2018/CHAITRA 2, 1940 �वा��य और प

MINISTRY OF HEALTH AND FAMILY WELFARE

(Department of Health and Family Welfare)

NOTIFICATION

New Delhi, the 23rd March, 2018

G.S.R. 277(E).—Whereas the draft of certain rules further to amend the Drugs and Cosmetics Rules, 1945 was published as required under sub-section(1) of section 12 and sub-section (1) of section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940) in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide notification of the Government of India in the Ministry of Health and Family Welfare, Department of Health and Family Welfare, number

G.S.R. 1357(E), dated the 1st November, 2017 inviting objections and suggestions from all persons likely to be affected thereby before the expiry of a period of forty-five days from the date on which copies of the Official Gazette containing the said notification were made available to the public;

And whereas, the copies of the said Official Gazette were made available to the public on 1st November, 2017; And whereas, objections and suggestions received from the public on the said rules have been considered by the Central Government;

Now, therefore, in exercise of the powers conferred by section 12 and section 33 of the said Act, the Central Government, after consultation with the Drugs Technical Advisory Board, hereby makes the following rules further to amend the Drugs and Cosmetics Rules, 1945, namely,-

1. (1) These rules may be called the Drugs and Cosmetics (Second Amendment) Rules, 2018.

(2) They shall come into force on the date of their publication in the Official Gazette.

2. In the Drugs and Cosmetics Rules, 1945, in Schedule H, after serial number 537 and the entries relating thereto, the following serial numbers and entries shall be inserted, namely,- “538. Alclometasone

539. Beclomethasone

540. Betamethasone

541. Desonide

542. Desoximetasone

543. Dexamethasone

544. Diflorasone diacetate

545. Fluocinonide

546. Fluocinolone acetonide

547. Halobetasol propionate

548. Halometasone

549. Methylprednisone

550. Prednicarbate

551. Triamcinolone acetonide. ”.

SUNIL SHARMA, Jt. Secy.

Note: The principal rules were published in the Gazette of India vide notification No. F.28-10/45-H (1) dated 21 st December, 1945 and last amended vide notification number

G.S.R. 222(E), dated 13 th March, 2018.

and Published by the Controller of Publications, Delhi-110054.

ALOK KUMAR

Provisions this notification answers to

Read out of the instrument itself: an enabling provision is one it says it was made under, which is the power it rests on. The rest it names without resting on.

Other instruments under the same Act

All of the The Drugs and Cosmetics Act, 1940